03-12-2025Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox…
12-16-2024Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild…
11-22-2024Cross-posted from CDC Health Alert Network Distributed via the CDC Health Alert Network November 18, 2024, 5:30 PM ET CDCHAN-00519 Summary The Centers for…
05-24-2024In its Morbidity and Mortality Weekly Report, CDC has released the results of studies highlighting the protection offered by the two-dose JYNNEOS mpox vaccine;…
05-16-2024The STOMP trial is evaluating the antiviral drug tecovirimat (TPOXX) as a treatment for mpox. Learn how individuals, providers, and community organizations can…
03-26-2024During the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), HIV.gov spoke with Dr. John Brooks, chief medical officer of CDC's Division of…
06-07-2023As sexually transmitted infections (STIs), including the recent mpox outbreak, continue to have a disproportionate impact on people with HIV, the Health…
05-25-2023Cross-posted from NIAID Now Mpox has been present in west, central and east Africa for decades, with the first human case identified in 1970. In May 2022, a…
05-18-2023On May 18, 2023, CDC issued in its Morbidity and Mortality Weekly Report (PDF, 0.99MB) (MMWR) the results of two studies highlighting the effectiveness of the…
03-21-2023Register for an open, virtual gathering to discuss mpox research. When: Friday, March 31, 2023, at 9:30am ET (U.S. and Canada) In close collaboration with…
03-10-2023Last month, HIV.gov had the opportunity to speak with our colleagues from NIH, CDC, and HRSA and with community members about the latest research on HIV and…
11-21-2022Building Healthy Online Communities (BHOC) invites the community to add vaccine events and help promote its community-developed monkeypox vaccine locator tool,…
10-26-2022Cross-posted from: Centers for Disease Control and Prevention Today, CDC issued in its Morbidity and Mortality Weekly Report (MMWR) the results of clinical…
10-18-2022Today, CDC published a science brief on the detection and transmission of monkeypox, summarizing the latest available published research on: Affected…
09-29-2022Dear Partners, [September 28, 2022], CDC is announcing expanded eligibility for monkeypox vaccination so that more people may receive the vaccine before they…
09-12-2022Cross-posted from Centers for Disease Control and PreventionOn Friday, September 9, 2022, CDC issued in its Morbidity and Mortality Weekly Report (MMWR) the…
09-09-2022Cross-posted from NIAID Newsroom NIH Trial is Evaluating Intradermal Delivery to Expand the Vaccine Supply. Interested volunteers can visit clinicaltrials.gov…
09-07-2022A new community-developed monkeypox vaccine locator tool developed by Building Healthy Online Communities (BHOC) with public and private partners is available…
08-08-2022CDC has released Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection. On August 4, 2022, the United States declared…
08-03-2022The Panel on Opportunistic Infections in Adults and Adolescents (the Panel) updated the Guidelines for the Prevention and Treatment of Opportunistic Infections…